Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > TREM-1

TREM-1

Brief Information

Name:Triggering receptor expressed on myeloid cells 1
Target Synonym:Triggering Receptor Expressed On Myeloid Cells 1,CD354 Antigen,Triggering Receptor Expressed on Myeloid Cells-1,TREM-1,TREM1,CD354,Triggering receptor expressed on monocytes 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
TR1-H5251 Human Human TREM-1 / CD354 Protein, Fc Tag
TR1-H5251-structure
TR1-H5251-sds
ACRO Quality

Part of Bioactivity data

TR1-H5251-BLI
TREM-1 BLI

Loaded Human TREM-1, Fc Tag (Cat. No. TR1-H5251) on Protein A Biosensor, can bind Recombinant Human PGLYRP1/PGRP-S Protein, CF with an affinity constant of 18.5 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol
TR1-H5251-ELISA
TREM-1 ELISA

Immobilized Human TREM-1, Fc Tag (Cat. No. TR1-H5251) at 5 μg/mL (100 μL/well) can bind Recombinant Human PGLYRP1/PGRP-S Protein, CF with a linear range of 0.002-0.156 μg/mL (Routinely tested).

Protocol

Synonym Name

TREM1,CD354

Background

Triggering receptor expressed on myeloid cells 1 (TREM1) is also known as CD antigen CD354, and is a type I transmembrane protein with a single Ig-like domain. TREM1 is highly expressed in adult liver, lung and spleen than in corresponding fetal tissue. TREM-1 / CD354 stimulates neutrophil and monocyte-mediated inflammatory responses, and also triggers release of pro-inflammatory chemokines and cytokines, as well as increased surface expression of cell activation markers. Amplifier of inflammatory responses that are triggered by bacterial and fungal infections and is a crucial mediator of septic shock. TREM1 can interacts with TYROBP / DAP12.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Nangibotide LR-12 Phase 2 Clinical Inotrem Shock, Septic; Coronavirus Disease 2019 (COVID-19) Details
CEL383 CEL-383 Phase 1 Clinical Celsius Therapeutics Inc Inflammatory Bowel Diseases Details
TREM 1 antibody(Boehringer Ingelheim International Gmbh) TREM 1 antibody(Boehringer Ingelheim International Gmbh) Phase 1 Clinical Boehringer Ingelheim International Gmbh Immune System Diseases Details
PY-159 PY-159 Phase 1 Clinical Centre for the Commercialization of Antibodies and Biologics Solid tumours; Neoplasms Details
Nangibotide LR-12 Phase 2 Clinical Inotrem Shock, Septic; Coronavirus Disease 2019 (COVID-19) Details
CEL383 CEL-383 Phase 1 Clinical Celsius Therapeutics Inc Inflammatory Bowel Diseases Details
TREM 1 antibody(Boehringer Ingelheim International Gmbh) TREM 1 antibody(Boehringer Ingelheim International Gmbh) Phase 1 Clinical Boehringer Ingelheim International Gmbh Immune System Diseases Details
PY-159 PY-159 Phase 1 Clinical Centre for the Commercialization of Antibodies and Biologics Solid tumours; Neoplasms Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap